Clinical Trials Sponsored by Link America, Inc

Total 1223 results

Sumitomo Pharma America, Inc.
Syneos Health

Terminated

A Study of DSP-0337 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic Profile

Neoplasms

United States
Merz North America, Inc.
Registrat-Mapi

Completed

Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States (XCiDaBLE)

Cervical Dystonia | Blepharospasm

United States
Photocure
KARL STORZ Endoscopy-America, Inc.

Completed

Early Detection of Polyps and Colon Cancer by Fluorescence Imaging - a Dose-finding Study

Colorectal Cancer

Germany
Main Line Health
AstraZeneca; Sharpe-Strumia Research Foundation; Cancer Research Foundation of...

Unknown

The Effect of Nexium on Transmucosal Esophageal Leak

Esophagitis | Barrett's Esophagus | Reflux

United States
Bausch Health Americas, Inc.
Progenics Pharmaceuticals, Inc.

Withdrawn

Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer Subjects

Opioid-Induced Constipation

Canada, United States, France, Spain
Bausch Health Americas, Inc.
Progenics Pharmaceuticals, Inc.

Completed

A Study of Oral Methylnaltrexone (MNTX) for the Treatment of Opioid-Induced Constipation (OIC) in Participants With Chronic, Non-Malignant Pain

Opioid-Induced Constipation

United States
Radnor Registry Research, Inc
American Regent, Inc.

Completed

AMPED Outcomes Registry of Post-ED Pain Management (AMPED)

Soft Tissue Injuries | Dysmenorrhea | Fractures | Gouty Arthritis | Ureteral Colic

United States
Kaneka Americas Holding Inc.
KGK Science Inc.

Completed

A Study Investigating the Effect of Floradapt Mature Immune Defense on Nutrient Uptake and Digestive Health in a Healthy Elderly Population

Healthy

Canada
Bausch Health Americas, Inc.
Progenics Pharmaceuticals, Inc.

Completed

Study Evaluating MOA-728 Oral for the Treatment of OIBD in Subjects With Chronic Non-Malignant Pain

Constipation
Bausch Health Americas, Inc.
Progenics Pharmaceuticals, Inc.

Completed

A Study Evaluating Intravenous (IV) MOA-728 for the Treatment of Postoperative Ileus (POI) in Participants After Ventral Hernia Repair

Ileus

United States, South Africa, Canada, Hungary, Poland, Australia, Belgium, Germany, Italy, Korea, Republic of, Netherlands
Bausch Health Americas, Inc.
Progenics Pharmaceuticals, Inc.

Completed

Study Evaluating Subcutaneous Methylnaltrexone For Treatment Of Opioid-Induced Constipation In Patients With Advanced Illness

Opioid-Induced Constipation

United States, Australia, Belgium, Canada, France, Germany, Italy, Mexico, United Kingdom, Brazil, Spain, Sweden
Bausch Health Americas, Inc.
Progenics Pharmaceuticals, Inc.

Completed

Safety of Subcutaneous Methylnaltrexone for Opioid-Induced Constipation in Patients With Advanced Illness

Opioid-Induced Constipation

United States, Australia, Belgium, Canada, France, Germany, Italy, Mexico, Portugal, United Kingdom
BioLite, Inc.
American BriVision Corporation

Not yet recruiting

A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients

Major Depressive Disorder

United States
American Gene Technologies International Inc.

Enrolling by invitation

Long-term Follow-up of Study Participant Treated With Lentiviral-Based Genetically Modified Autologous Cell Product ,AGT103-T

HIV

United States
GlaxoSmithKline
Bausch Health Americas, Inc.

Terminated

Study in Pediatric Subjects With Epilepsy

Epilepsy

United States
GlaxoSmithKline
Bausch Health Americas, Inc.

Terminated

Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS

Epilepsy

United States
Bayer
Bausch Health Americas, Inc.

Completed

A Pharmacodynamic Study Comparing Zegerid® and Prilosec OTC® (Study CL2008-02)(P07814)(COMPLETED)

Gastric Acid | Human Experimentation
American Medical Systems
Quintiles, Inc.

Completed

JetTouch Injection System to Deliver Saline Into the Bladder Wall of Healthy Volunteers

Healthy Subjects

United Kingdom
Apple Inc.
American Heart Association

Recruiting

Apple Heart & Movement Study

Prevention

United States
American Gene Technologies International Inc.

Completed

Study to Evaluate the Safety of a Gene and Cell Therapy Product in Participants With HIV That is Well-Controlled on Antiretroviral Therapy

HIV

United States
American Gene Technologies International Inc.

Enrolling by invitation

An Antiretroviral Treatment Interruption (ATI) Study to Evaluate the Impact of Genetically Modified Autologous Cells (AGT103-T) to Suppress Human Immunodeficiency Virus Replication in the Absence of Antiretroviral Therapy

HIV

United States
GlaxoSmithKline
Bausch Health Americas, Inc.

Terminated

Dose-Optimization, Adjunctive Treatment Study of Ezogabine/Retigabine Immediate Release in Partial-onset Seizures

Seizures

United States, Greece
Bausch Health Americas, Inc.
Pfizer

Completed

A a Single Dose Efficacy Study in Inducing Laxation in Advance Illness Patients

Advanced Illness Patients With Opioid Induced Constipation

United States
GlaxoSmithKline
Bausch Health Americas, Inc.

Completed

Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy (RESTORE2)

Seizures

Spain, Australia, Israel, Ukraine, Belgium, United States, South Africa, Hungary, United Kingdom, France, Germany, Poland, Russian Federation
GlaxoSmithKline
Bausch Health Americas, Inc.

Completed

Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy (RESTORE1)

Seizures

United States, Canada, Argentina, Brazil, Mexico
Alimentiv Inc.
Takeda Development Center Americas, Inc.

Recruiting

Determination of the Optimal Treatment Target in Ulcerative Colitis (VERDICT)

Colitis, Ulcerative

Canada, United Kingdom, Poland, Italy, United States, Belgium, France, Netherlands, Belarus, Ukraine
Bausch Health Americas, Inc.
Progenics Pharmaceuticals, Inc.

Completed

Study Evaluating Oral MOA-728 For The Treatment Of OIBD In Subjects With Chronic Non-Malignant Pain

Constipation

United States
Bausch Health Americas, Inc.
Progenics Pharmaceuticals, Inc.

Completed

Study Evaluating the Efficacy and Safety of Subcutaneous Methylnaltrexone (MOA-728) for the Treatment of Opioid-Induced-Constipation

Constipation

Korea, Republic of, Taiwan
Bausch Health Americas, Inc.
Progenics Pharmaceuticals, Inc.

Completed

Study Evaluating Subcutaneous MOA-728 for the Treatment of Opioid-Induced Constipation (OIC) in Subjects With Chronic Non-Malignant Pain

Constipation

United States
Recros Medica, Inc.

Completed

The PREFORM Study: Rotational Fractional Resection for Submental Contouring

Lipodystrophy | Skin Laxity

United States
Mirabilis Medica, Inc.

Unknown

Directed Ablation of Uterine Fibroids Using a Noninvasive Approach (DIANA)

Uterine Leiomyoma
Mirabilis Medica, Inc.

Completed

Clinical Study of the Mirabilis High-Intensity Focused Ultrasound System for Non-Invasive Treatment of Uterine Fibroids

Uterine Fibroids (Leiomyomas)

Mexico
Gamma Medica, Inc.

Withdrawn

MBI and Breast Tomosynthesis Screening Accuracies in Patients With Dense Breast Tissue

Breast Neoplasms
Recros Medica, Inc.

Unknown

The INFORM Study: Rotational Fractional Resection for Submental Contouring

Skin Laxity

United States
Serica Technologies, Inc.

Completed

SeriACL™ Device (Gen IB) Trial for Anterior Cruciate Ligament (ACL) Repair

Anterior Cruciate Ligament Reconstruction

Belgium, Germany, Austria
American Gene Technologies International Inc.

Unknown

Developing a Functional Cure for HIV Disease: Clinical Specimen Collection From HIV Positive Individuals

HIV Infections

United States
Bausch Health Americas, Inc.
Pfizer

Completed

Study Evaluating Long-Term Safety of MOA-728 in Participants With Opioid-Induced Constipation

Constipation

Canada, United States, Colombia, Korea, Republic of, Australia, Spain
Bausch Health Americas, Inc.
Parexel

Completed

The Plecanatide Chronic Idiopathic Constipation (CIC) Study

Chronic Idiopathic Constipation

United States
Bayer
Bausch Health Americas, Inc.

Completed

A Pharmacodynamic Study Comparing Zegerid® and Prilosec OTC® (CL2007-17 )(P07813)(COMPLETED)

Gastric Acid | Human Experimentation
Cellivery Therapeutics, Inc.
Labcorp Corporation of America Holdings, Inc

Suspended

iCP-NI - Safety, Tolerability, Pharmacokinetic, and Immunogenicity Study in Healthy Male and Female Subjects

Healthy Volunteers

United States
Recros Medica, Inc.

Completed

CONFORM: Rotational Fractional Resection for Submental Contouring

Lipodystrophy | Skin Laxity

United States
Serica Technologies, Inc.

Unknown

SeriACL™ Device Trial for Anterior Cruciate Ligament (ACL) Reconstruction

Knee Injuries | Anterior Cruciate Ligament

Germany, Norway
Aurinia Pharmaceuticals Inc.
Labcorp Corporation of America Holdings, Inc

Not yet recruiting

Long-Term Voclosporin Treatment in Adolescent Subjects With Lupus Nephritis (VOCAL-EXT)

Adolescent Lupus Nephritis

United States
Blessing Corporate Services, Inc
Takeda Pharmaceuticals North America, Inc.

Withdrawn

Aralast NP With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection

Pneumonia, Viral | Covid19

United States
UNC Lineberger Comprehensive Cancer Center
American Cancer Society, Inc.

Completed

Chemotherapy-related Cognitive Impairment and Acute Leukemia

Acute Myeloid Leukemia

United States
Fundacio Puigvert
KARL STORZ Endoscopy-America, Inc.

Recruiting

En Bloc Bladder Tumor Resection: Prospective Randomized Study

Bladder Cancer | Urothelial Carcinoma Bladder

Spain
Merz North America, Inc.
Merz Pharmaceuticals GmbH

Completed

Safety, Effectiveness and Participant Satisfaction Study of a Dermal Filler (of RADIESSE® (+) Lidocaine) in the Treatment of Ageing Signs in the Face (RaLido)

Signs of Facial Aging With Volume Loss in the Upper Cheeks, Nasolabial Folds and Marionette Lines

Germany
Merz Pharmaceuticals GmbH
Merz North America, Inc.

Completed

Blepharospasm Patient Survey for Patients With Blepharospasm

Blepharospasm

United States
Augusta University
Takeda Pharmaceuticals North America, Inc.

Completed

Effect of Lubiprostone on Methanogenesis and Bowel Function in Chronic Constipation.

Chronic Constipation, Methanogenesis

United States
Boston University
Takeda Pharmaceuticals North America, Inc.

Completed

Use of Expressive Writing in Irritable Bowel Syndrome (IBS)

Irritable Bowel Syndrome

Clinical Trials Sponsored by Link America, Inc

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations